- Home
- COEP vs GDTC Comparison
COEP vs GDTC Comparison
Compare COEP & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- GDTC
- Stock Information
- Founded
- COEP 2017
- GDTC 2018
- Country
- COEP United States
- GDTC Singapore
- Employees
- COEP N/A
- GDTC N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- COEP Health Care
- GDTC Health Care
- Exchange
- COEP Nasdaq
- GDTC Nasdaq
- Market Cap
- COEP 27.4M
- GDTC 21.5M
- IPO Year
- COEP N/A
- GDTC 2023
- Fundamental
- Price
- COEP $11.16
- GDTC $1.86
- Analyst Decision
- COEP
- GDTC Buy
- Analyst Count
- COEP 0
- GDTC 1
- Target Price
- COEP N/A
- GDTC $5.00
- AVG Volume (30 Days)
- COEP 56.9K
- GDTC 18.1K
- Earning Date
- COEP 08-15-2025
- GDTC 01-01-0001
- Dividend Yield
- COEP N/A
- GDTC N/A
- EPS Growth
- COEP N/A
- GDTC N/A
- EPS
- COEP N/A
- GDTC N/A
- Revenue
- COEP $62,874.00
- GDTC $368,838.00
- Revenue This Year
- COEP N/A
- GDTC $5.37
- Revenue Next Year
- COEP N/A
- GDTC N/A
- P/E Ratio
- COEP N/A
- GDTC N/A
- Revenue Growth
- COEP N/A
- GDTC N/A
- 52 Week Low
- COEP $2.31
- GDTC $1.20
- 52 Week High
- COEP $13.70
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- COEP 59.53
- GDTC 35.89
- Support Level
- COEP $11.30
- GDTC $1.85
- Resistance Level
- COEP $12.71
- GDTC $1.95
- Average True Range (ATR)
- COEP 0.89
- GDTC 0.10
- MACD
- COEP 0.18
- GDTC -0.02
- Stochastic Oscillator
- COEP 54.39
- GDTC 23.53
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.